Complete case analysis | Including prior stages | ||||||||
---|---|---|---|---|---|---|---|---|---|
Non-organ confined (pT3-T4 or pN+) | Organ confined (pT0-T2 and pN0) | Unadjusted odds ratio (95% CI) | Adjusteda odds ratio (95% CI) | Unadjusted odds ratio (95% CI) | Adjusteda odds ratio (95% CI) | ||||
n | % | n | % | ||||||
Non-users (n = 1521) | 859 | 56.5 | 662 | 43.5 | Ref. | Ref. | Non-users (n = 2081) | Ref. | Ref. |
AD users (n = 111) | 69 | 62.2 | 42 | 37.8 | 1.27 (0.85–1.88) | 1.16 (0.78–1.74) | AD users (n = 142) | 1.29 (0.92–1.81) | 1.19 (0.84–1.69) |